Last update 15 May 2025

CJRB-101

Overview

Basic Info

Drug Type
Microbiota
Synonyms
CJRB-101
Target
TLR4
Action
agonists
Mechanism
TLR4 agonists(Toll like receptor 4 agonists)
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases
Active Indication
Advanced cancerAdvanced Malignant Solid NeoplasmMelanoma+ [3]
Inactive Indication-
Originator Organization
CJ Bioscience, Inc.CJ Bioscience, Inc.
Active Organization
CJ Bioscience, Inc.CJ Bioscience, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CJRB-101
NCT05877430
/ RecruitingPhase 1/2
Phase 1/2 Open Label, Safety and Preliminary Efficacy Study of a Live Biotherapeutic Product (CJRB-101) in Combination With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
100 Clinical Results associated with CJRB-101
Login to view more data
100 Translational Medicine associated with CJRB-101
Login to view more data
100 Patents (Medical) associated with CJRB-101
Login to view more data
100 Deals associated with CJRB-101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 2
United States
CJ Bioscience, Inc.CJ Bioscience, Inc.
11 Sep 2023
Advanced Malignant Solid NeoplasmPhase 2
United States
CJ Bioscience, Inc.CJ Bioscience, Inc.
11 Sep 2023
MelanomaPhase 2
United States
CJ Bioscience, Inc.CJ Bioscience, Inc.
11 Sep 2023
Neoplasm MetastasisPhase 2
United States
CJ Bioscience, Inc.CJ Bioscience, Inc.
11 Sep 2023
Non-Small Cell Lung CancerPhase 2
United States
CJ Bioscience, Inc.CJ Bioscience, Inc.
11 Sep 2023
Squamous Cell Carcinoma of Head and NeckPhase 2
United States
CJ Bioscience, Inc.CJ Bioscience, Inc.
11 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free